- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05023226
Effectiveness of Recruitment Maneuvers and Lung Protective Ventilation Strategy in ARDS (ARDS)
The study was designed to comparison the effectiveness of recruitment maneuvers(RM) and lung protective ventilation strategy(LPVS) for patients with moderate to severe ARDS.
ARDS patients were randomly divided into two groups, the experimental group (LPVS+RM group) and the control group (LPVS group). The method of RM refers to that under FiO2=100% oxygen concentration and fixed inspiratory pressure (15cmH2O), the PEEP starts from 10 cmH2O and increases at a pressure of 5 cmH2O every minute until the Peak inspiratory Pressure(PIP) reaches 55cmH2O, and the arterial blood oxygen is monitored at the same time. The pressure point when the partial pressure of arterial oxygen PaO2+PaCO2≧400mmHg is the best PEEP. The primary endpoint indicators were oxygenation index(OI), extravascular lung water index (EVLWI) and lung ultrasound score(LUS) from day 1 to day 7. The secondary outcome indicators were the ventilator days, length of stay in the ICU (days), and ICU mortality.
Study Overview
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Zi-Tin Kuan, RN
- Phone Number: 886-966083885
- Email: kuan.zitin@gmail.com
Study Locations
-
-
Wufeng
-
Taichung, Wufeng, Taiwan, 41354
- Asia University
-
Contact:
- Jiun-Yi Wang, Ph.D.
- Phone Number: 1861 886-42332-3456
- Email: jjwang@asia.edu.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 20 to 70 years old.
- Patients with hypoxemia receiving endotracheal mechanical ventilation therapy.
- The ARDS diagnostic criteria of Berlin Definition, arterial oxygen tension [PaO2]/fractional inspired oxygen [FiO2] ratio (PaO2/FiO2) <200 mm Hg, recent appearance of bilateral pulmonary infiltrates consistent with edema and no clinical evidence of left atrial hypertension.
- Within 72 hours after ARDS diagnosis.
Exclusion Criteria:
- Pregnancy.
- Participate in other interventional trials at the same time during the acceptance period.
- Severe trauma combined with rib fracture or pneumothorax, subcutaneous emphysema, and mediastinal air accumulation within three months.
- Severe chronic respiratory diseases that require long-term use of oxygen therapy or home mechanical ventilation.
- Have a history of cachexia or terminal cancer.
- Use immunosuppressants, chemotherapy or radiation therapy.
- Contraindications for hypercapnia, such as patients with acute brain injury due to intracranial hypertension or craniotomy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: LPVS group
The general ventilator setting.
|
LPVS was used by the pressure-controlled mode and the PEEP was titrated by the level of FiO2 to keep the saturation of oxygen (SaO2) more than 90%.
The level of pressure control was adjusted to maintain low tidal volume (6-8 mL/kg predicted body weight [PBW]) strategy.
The respiratory rate and tidal volume were setting to avoid unstable hemodynamic data and adjusted by blood gas data and lung mechanics.
Other Names:
|
Experimental: LPVS + RM group
Recruitment maneuver.
|
LPVS was used by the pressure-controlled mode and the PEEP was titrated by the level of FiO2 to keep the saturation of oxygen (SaO2) more than 90%.
The level of pressure control was adjusted to maintain low tidal volume (6-8 mL/kg predicted body weight [PBW]) strategy.
The respiratory rate and tidal volume were setting to avoid unstable hemodynamic data and adjusted by blood gas data and lung mechanics.
Other Names:
RM refers to that under FiO2=100% oxygen concentration and fixed inspiratory pressure (15cmH2O), the PEEP starts from 10 cmH2O and increases at a pressure of 5 cmH2O every minute until the Peak inspiratory Pressure(PIP) reaches 55cmH2O, and the level was fixed to 40 seconds in each increment.
Then, the ventilator was transferred to PEEP-titration phase, the PEEP was adjusted to 25 cm H2O, and it was reduced by increments of 5 cm H2O each time.
The each increment was fixed to 5 minutes till the end-maneuver PEEP.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oxygenation index(OI)
Time Frame: Baseline - 72 hrs after enrollment
|
Difference in OI between baseline and 72 hrs after enrollment 【The oxygenation index assesses the intensity of ventilatory support that is needed to maintain adequate oxygenation.
The formula is: Oxygenation index = (FiO2 x PAW) / PaO2.
The lower the OI(<25) the better the outcome】
|
Baseline - 72 hrs after enrollment
|
Extravascular lung water index (EVLWI)
Time Frame: Baseline - 72 hrs after enrollment
|
Difference in EVLWI between baseline and 72 hrs after enrollment 【EVLWI is the amount of water that is contained in the lungs outside the pulmonary vasculature.
In the normal lung, the value of the normal EVLW is <7 mL/kg of body weight】
|
Baseline - 72 hrs after enrollment
|
Lung ultrasound score(LUS)
Time Frame: Baseline - 72 hrs after enrollment
|
Difference in LUS between baseline and 72 hrs after enrollment 【LUS is a score that measures lung aeration, score ranging from 0 to 36 points, the higher the score is mean the worse the ventilation of the lungs】
|
Baseline - 72 hrs after enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ventilator days
Time Frame: Removal of endotracheal tube day - Insertion endotracheal tube day + 1 day
|
Removal of endotracheal tube without ventilator support days
|
Removal of endotracheal tube day - Insertion endotracheal tube day + 1 day
|
Length of stay in the ICU (days)
Time Frame: Transfer out of ICU day - Admission to ICU day + 1 day
|
Total days of admission ICU
|
Transfer out of ICU day - Admission to ICU day + 1 day
|
ICU mortality
Time Frame: During ICU course
|
In ICU death after admission to the ICU
|
During ICU course
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Zi-Tin Kuan, RN, Asia University Hospital
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- AUH-CT-ZK01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ARDS
-
National University Health System, SingaporeActive, not recruiting
-
King Abdul Aziz Specialist HospitalCompleted
-
Southeast University, ChinaCompleted
-
Magni FedericoUnknown
-
Wolfson Medical CenterUnknown
-
Southeast University, ChinaFirst Affiliated Hospital of Wannan Medical CollegeRecruiting
-
University Hospital, AngersCompleted